| Long name: |
DRAK2 Primary Polyclonal Antibody |
| Also known as: |
DRAK2 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
DRAK2 |
| Specificity: |
This is a highly specific antibody against DRAK2 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human DRAK2 |
| Gene ID number: |
9262 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Certain serine/threonine protein kinases, DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues, DRAKs contain an N terminal kinase domain and a C terminal regulation domain, DRAKs have high sequence homology to DAP and ZIP kinases, Overexpression of DRAK2 induces apoptosis, Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase related apoptosis inducing protein kinases), and they represent a novel family of serine/threonine kinases, are mediators of apoptosis, such as ASK1 and RIP, which mediates apoptosis through their catalytic activities, Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
DAP kinase related apoptosis inducing protein kinase 2, DRAK 2, Death associated protein kinase related 2, ST17B_HUMAN, STK17B, Serine/threonine kinase 17b, Serine/threonine kinase 17b apoptosis inducing, Serine/threonine protein kinase 17B, DAP kinase related apoptosis inducing protein |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
DRAK2 |
| Short name: |
DRAK2 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
DRAK2 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
11396 |
| Gene: |
STK17B |
More about : STK17B |
| Long gene name: |
serine/threonine kinase 17b |
| Synonyms gene name: |
serine/threonine kinase 17b (apoptosis-inducing) |
| Synonyms: |
DRAK2 |
| Synonyms name: |
death-associated protein kinase-related 2 |
| Locus: |
2q32, 3 |
| Discovery year: |
1999-05-21 |
| GenBank acession: |
AB011421 |
| Entrez gene record: |
9262 |
| Pubmed identfication: |
9786912 |
| Classification: |
Death associated protein kinases |
| Havana BLAST/BLAT: |
OTTHUMG00000132735 |